This inventor holds 7 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 7 EPO patents. Top assignee: Suppremol Gmbh. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
6 out of 9 Years Active: 2019-2024
Title: The Innovations of Thomas Pohl
Introduction
Thomas Pohl is a notable inventor based in Neuried, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of soluble Fc receptors. With a total of seven patents to his name, Pohl's work has the potential to impact the treatment of various autoimmune diseases and infections.
Latest Patents
Among his latest patents, Pohl has developed highly concentrated formulations of soluble Fc receptors. These formulations specifically focus on high concentrations of the soluble FcγRIIB receptor. The invention relates to the use of these formulations as pharmaceutical compounds for treating autoimmune diseases, infections, and other conditions where the immune system plays a crucial role.
Career Highlights
Throughout his career, Thomas Pohl has worked with several companies, including Suppremol GmbH and Lifecodexx AG. His expertise in the field has allowed him to contribute to innovative solutions in pharmaceutical science.
Collaborations
Pohl has collaborated with notable individuals in his field, including Peter Sondermann and Dominik Ter Meer. These collaborations have further enhanced his research and development efforts.
Conclusion
Thomas Pohl's contributions to the field of pharmaceutical formulations demonstrate his commitment to innovation and improving healthcare solutions. His patents and collaborations reflect a dedication to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile